应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
TGTX TG Therapeutics Inc.
交易中 01-14 10:45:31 EST
29.35
+1.48
+5.31%
最高
33.24
最低
29.30
成交量
377.04万
今开
31.11
昨收
27.87
日振幅
14.14%
总市值
46.60亿
流通市值
43.44亿
总股本
1.59亿
成交额
1.18亿
换手率
2.55%
流通股本
1.48亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
TG Therapeutics股价创去年11月以来新高，初步2025年销售额超预期，收盘大涨12.9%
美股速递 · 22:44
TG Therapeutics股价创去年11月以来新高，初步2025年销售额超预期，收盘大涨12.9%
异动解读 | TG Therapeutics盘中大涨17.83%，因2025销售业绩超预期及2026年营收指引乐观
异动解读 · 22:34
异动解读 | TG Therapeutics盘中大涨17.83%，因2025销售业绩超预期及2026年营收指引乐观
异动解读 | 初步销售额超预期及2026年营收指引乐观，TG Therapeutics盘前大涨7.18%
异动解读 · 18:14
异动解读 | 初步销售额超预期及2026年营收指引乐观，TG Therapeutics盘前大涨7.18%
周三值得关注的股票：Netflix、美国银行、花旗
投资观察 · 18:14
周三值得关注的股票：Netflix、美国银行、花旗
异动解读 | 初步销售额超预期及2026年营收指引乐观，TG Therapeutics夜盘大涨7.61%
异动解读 · 16:40
异动解读 | 初步销售额超预期及2026年营收指引乐观，TG Therapeutics夜盘大涨7.61%
TG Therapeutics公布2025年第四季度及全年初步净产品收入、2026年营收指引与预期研发里程碑
美股速递 · 05:26
TG Therapeutics公布2025年第四季度及全年初步净产品收入、2026年营收指引与预期研发里程碑
TG Therapeutics完成Briumvi新简化给药方案的三期Enhance试验的入组工作
美股速递 · 2025-10-28
TG Therapeutics完成Briumvi新简化给药方案的三期Enhance试验的入组工作
TG Therapeutics宣布将在2025年欧洲多发性硬化症治疗和研究委员会年会上公布Briumvi®多发性硬化症数据展示安排
美股速递 · 2025-09-10
TG Therapeutics宣布将在2025年欧洲多发性硬化症治疗和研究委员会年会上公布Briumvi®多发性硬化症数据展示安排
TG Therapeutics宣布完成现有股份回购计划并授权新的1亿美元回购方案
美股速递 · 2025-09-03
TG Therapeutics宣布完成现有股份回购计划并授权新的1亿美元回购方案
异动解读 | TG Therapeutics股价盘中大跌13.45%，季度业绩不及预期
异动解读 · 2025-08-04
异动解读 | TG Therapeutics股价盘中大跌13.45%，季度业绩不及预期
异动解读 | TG Therapeutics股价盘中暴跌13.45%，财报公布在即投资者忧虑加剧
异动解读 · 2025-08-04
异动解读 | TG Therapeutics股价盘中暴跌13.45%，财报公布在即投资者忧虑加剧
Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元，同比增加84.53%
市场透视 · 2025-03-09
Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元，同比增加84.53%
Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元
市场透视 · 2025-03-07
Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元
Tg Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 2025-03-04
Tg Therapeutics, Inc.盘中异动 股价大涨5.00%
TG Therapeutics 2024年第四季度GAAP每股收益$0.15，与预期一致，销售额$108.19M超$99.95M预期
财报速递 · 2025-03-03
TG Therapeutics 2024年第四季度GAAP每股收益$0.15，与预期一致，销售额$108.19M超$99.95M预期
Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%
市场透视 · 2025-03-01
Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%
Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
市场透视 · 2025-02-25
Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元
市场透视 · 2025-02-01
Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元
Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%
市场透视 · 2025-01-27
Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%
Tg Therapeutics, Inc.盘中异动 股价大涨5.03%报30.50美元
市场透视 · 2025-01-25
Tg Therapeutics, Inc.盘中异动 股价大涨5.03%报30.50美元
加载更多
公司概况
公司名称：
TG Therapeutics Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司，专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外，TG还获得了美国食品药品监督管理局（FDA）的BRIUMVI（ublituximab-xiiy）批准，用于治疗成人复发性多发性硬化症（RMS）患者，包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。
发行价格：
--
{"stockData":{"symbol":"TGTX","market":"US","secType":"STK","nameCN":"TG Therapeutics Inc.","latestPrice":29.35,"timestamp":1768405529293,"preClose":27.87,"halted":0,"volume":3770361,"delay":0,"floatShares":148000000,"shares":158759451,"eps":2.776003,"marketStatus":"交易中","change":1.48,"latestTime":"01-14 10:45:31 EST","open":31.11,"high":33.2399,"low":29.3,"amount":118106735.531967,"amplitude":0.141367,"askPrice":29.47,"askSize":100,"bidPrice":29.33,"bidSize":250,"shortable":3,"etf":0,"ttmEps":2.776003,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768424400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1128657600000,"exchange":"NASDAQ","adjPreClose":27.87,"preHourTrading":{"tag":"盘前","latestPrice":31.12,"preClose":27.87,"latestTime":"09:29 EST","volume":109362,"amount":3368170.79313,"timestamp":1768400982721},"postHourTrading":{"tag":"盘后","latestPrice":29.8195,"preClose":27.87,"latestTime":"19:59 EST","volume":347969,"amount":10236701.2684,"timestamp":1768352398051},"volumeRatio":6.921855,"impliedVol":0.6058,"impliedVolPercentile":0.3108},"requestUrl":"/m/hq/s/TGTX","defaultTab":"news","newsList":[{"id":"1166654438","title":"TG Therapeutics股价创去年11月以来新高，初步2025年销售额超预期，收盘大涨12.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166654438","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166654438?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:44","pubTimestamp":1768401886,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc. (TGTX) 股价今日强势攀升，收盘录得12.9%的可观涨幅，创下去年11月以来的最高水平。此番强劲表现主要得益于公司发布的初步数据显示，其2025年的销售额预期已超越市场共识。\n市场对这家生物技术公司的前景展现出浓厚兴趣，投资者情绪受到积极销售指引的显著提振。股价的飞跃反映出市场对其未来增长潜力的重新评估和坚定信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"1104121370","title":"异动解读 | TG Therapeutics盘中大涨17.83%，因2025销售业绩超预期及2026年营收指引乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1104121370","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104121370?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:34","pubTimestamp":1768401285,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.（TGTX）今日盘中大涨17.83%，股价表现强劲。消息面上，公司公布的2025年初步净销售额为6.16亿美元，超出此前预期的6亿美元。同时，公司对2026年的营收指引为8.75亿至9亿美元，显示出对未来增长的乐观预期。公司首席执行官Michael Weiss表示，多发性硬化症药物Briumvi的销售表现强劲，2025年在美国的销售额预计将达到5.94亿美元，同比增长约92%。此外，分析师预计2026年底推出的皮下注射版Briumvi将成为公司业绩的“大拐点”，进一步增强了市场对该公司未来增长的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"1133474703","title":"异动解读 | 初步销售额超预期及2026年营收指引乐观，TG Therapeutics盘前大涨7.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133474703","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133474703?lang=zh_cn&edition=full","pubTime":"2026-01-14 18:14","pubTimestamp":1768385685,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.（TGTX）今日盘前大涨7.18%，股价表现强劲。消息面上，公司公布的2025年初步净销售额为6.16亿美元，超出此前预期的6亿美元。同时，公司对2026年的营收指引为8.75亿至9亿美元，显示出对未来增长的乐观预期。公司首席执行官Michael Weiss表示，若多发性硬化症药物Briumvi获得批准，新的静脉输注计划有望短期内提升收入，进一步增强了市场信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"1145027777","title":"周三值得关注的股票：Netflix、美国银行、花旗","url":"https://stock-news.laohu8.com/highlight/detail?id=1145027777","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145027777?lang=zh_cn&edition=full","pubTime":"2026-01-14 18:14","pubTimestamp":1768385673,"startTime":"0","endTime":"0","summary":"美国银行即将发布季度财报，富国银行和花旗也将同步公布业绩。流媒体巨头奈飞正筹备对华纳兄弟探索旗下工作室及HBO Max业务发起全现金收购要约，而派拉蒙仍在推进竞争性报价。奈飞股价在盘前交易中上涨1.5%。联邦住房金融局局长比尔·普尔特在访谈中质疑房企股票回购计划，而头部上市房企仍宣称将在2025年实施大规模回购。该公司在伦敦市场的股价下跌1.5%。其股价在盘后交易中大涨7%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WBD","LU2413666699.HKD","LU2028103732.USD","BK4592","LU0154236417.USD","LU1983260115.SGD","IE00BJTD4V19.USD","LU2430703251.USD","LU1201861249.SGD","LU0106831901.USD","LU2023250504.SGD","LU1839511570.USD","LU2054465674.USD","LU2471134952.CNY","BK4551","LU1084165304.USD","IE00BK4W5M84.HKD","LU0985320562.USD","LU2092627202.USD","IE00B1BXHZ80.USD","IE000YTNTUN2.SGD","LU0942090050.USD","LU2361044865.SGD","BK4088","LU1366192091.USD","LU2361044949.HKD","LU2430703178.SGD","NVDD","LU0210533765.USD","LU2065171402.SGD","IE0001KFT4U8.USD","LU1629891620.HKD","LU1880398471.USD","LU2360032135.SGD","BK4524","LU1923622291.USD","NVDA","LU1363072403.SGD","IE00BJLML261.HKD","IE00B19Z8X17.USD","LU2211815571.USD","LU0708994859.HKD","LU1868836757.USD","LU0310800965.SGD","IE000M9KFDE8.USD","LU2461242641.AUD","IE00BMPRXN33.USD","LU1674673691.USD","LU2125154935.USD","LU0061474705.USD","IE00BLSP4452.SGD","LU1623119135.USD","BK4554","LU0107464264.USD","LU0211327993.USD","LU2250418816.HKD","BK4533","LU0640476718.USD","LU2168564495.EUR","LU2294711713.HKD","LU2403377893.USD","LU0251132253.USD","IE00BQXX3F31.USD","IE0002270589.USD","LU0354030511.USD","LU2433249047.HKD","IE0004086264.USD","LU0823421416.USD","LU0128525689.USD","BK4581","BK4608","LU2552382058.USD","BK4553","LU1366333091.USD","BK4596","LU0238689110.USD","LU1934455863.HKD","LU1496350502.SGD","LU0256863811.USD","LU1691799644.USD","LU1267930490.SGD","LU1496350171.SGD","LU0306806265.USD","LU0106261372.USD","LU1778281490.HKD","NFLX","LU1989764748.USD","LU1868836591.USD","IE00BFXG1179.USD","LU0316494557.USD","LU2462157665.USD","LU1316542783.SGD","SGXZ23171101.USD","LU0234572021.USD","SG9999015978.USD","SG9999001424.SGD","LU0308772762.SGD","IE00BYXW3230.USD","LU1267930573.SGD","LU1880398554.USD","LU0724617625.USD","HK0000320264.USD","LU1037948541.HKD","LU1992135472.HKD","LU2271345857.HKD","HK0000306685.HKD","LU2491049909.HKD","IE000ITXATA3.USD","IE00BFSS8Q28.SGD","LU0390134368.USD","LU0477156953.USD","LU1804176565.USD","LU1718418525.SGD","LU2362540622.SGD","LU0097036916.USD","IE00B3M56506.USD","LU0081259029.USD","LU2420271590.USD","IE00BSNM7G36.USD","LU0070217475.USD","LU2089985449.USD","LU2244417387.USD","HK0000320223.HKD","LU2106854487.HKD","LU1116320737.USD","SG9999015341.SGD","IE00BLSP4239.USD","LU0882574139.USD","LU0648001328.SGD","IE00BMPRXR70.SGD","LU2456880835.USD","IE0009G5SDU7.USD","IE00BBT3K403.USD","SG9999014575.USD","BAC","LU1119994496.HKD","LU1571399168.USD","LU2272731782.SGD","LU1815333072.USD","LU2471134879.HKD","SGXZ51526630.SGD","LU0056508442.USD","LU1668664300.SGD","IE00BDCRKT87.USD","LU2063271972.USD","LU0345769631.USD","LU2247934214.USD","IE00BJTD4N35.SGD","IE00BQXX3D17.EUR","LU0861579265.USD","LU2362541513.USD","LU0210536198.USD","IE0009356076.USD","IE00BZ1G4Q59.USD","NVDY","LU1989772923.USD","LU1935042488.USD","LU2077746001.SGD","LU0820562030.AUD","LU0127658192.USD","SG9999015945.SGD","HK0000306701.USD","LU0289739343.SGD","LU1127390331.HKD","LU0251142724.SGD","LU0786609619.USD","SGXZ81514606.USD","LU2237438978.USD","NVD2.UK","LU2129689514.USD","NVDS.UK","LU0310799852.SGD","LU0157215616.USD","LU1935043536.SGD","LU0353189763.USD","LU2362541273.HKD","NVD","LU0787776722.HKD","LU2242650005.HKD","LU2237957902.USD","LU2236285917.USD","LU1883839398.USD","LU0203345920.USD","IE00BD6J9T35.USD","SG9999002232.USD","IE00BWXC8680.SGD","LU1861127337.USD","LU1551013342.USD","LU1894683348.USD","LU2357305700.SGD","LU2125909916.SGD","LU0096362180.USD","LU2361045086.USD","LU0965508806.USD","3NVD.UK","BK4207","IE0005OL40V9.USD","SG9999002224.SGD","LU2065171311.SGD","BK4550","IE00B1XK9C88.USD","LU0072462426.USD","LU0124676726.USD","LU1323610961.USD","IE0004445015.USD","BK4605","LU0823421333.USD","LU0788109477.HKD","LU2092937148.SGD","LU1829250122.USD","LU0187121727.USD","IE000W1ABFV2.USD","LU2097344357.USD","LU1069344957.HKD","DIPS","IE00BKVL7J92.USD","LU2471134523.USD","BK4585","LU2381873111.SGD","LU1642822529.SGD","LU1280957306.USD","BK4507","LU1989764664.SGD","IE00BK4W5L77.USD","LU0965509101.SGD","LU2097344431.USD","LU0061474960.USD","SGXZ31699556.SGD","LU1506573853.SGD","IE00BKPKM429.USD","LU2023250330.USD","LU2756315318.SGD","LU0353189680.USD","BK4548","LU2471134796.USD","LU1242518931.SGD","IE00B4YYXB79.USD","LU0251131958.USD","LU0306807586.USD","LU1917777945.USD","LU1868837136.USD","LU0965509283.SGD","IE00B19Z8W00.USD","LU0345768740.USD","LU1244550577.SGD","LU2168563687.JPY","IE00B19Z3B42.SGD","LU1814569148.SGD","LU2322448957.HKD","BK4612","LU2756315664.SGD","BK4579","LU0345769128.USD","IE00BJJMRX11.SGD","LU2326559502.SGD","LU2360107168.USD","LU1951198990.SGD","BK4543","LU0868494708.USD","LU2896262040.SGD","LU0320765489.SGD","LU1815336760.USD","BK4549","LU1244550494.USD","IE00BFSS7M15.SGD","LU0980610538.SGD","LU1066051811.HKD","LU0109391861.USD","LU1066051225.USD","LU0868494617.USD","IE00BJJMRY28.SGD","LU1242518857.USD","BK4598","LU0175139822.USD","LU0079474960.USD","LU0310800379.SGD","LU1712237335.SGD","BK4588","LU0719512351.SGD","LU0211331839.USD","LU0708995401.HKD","LU1548497426.USD","LU0210528500.USD","SG9999018865.SGD","LU0276348264.USD","LU1935042991.SGD","LU0642271901.SGD","LU2265009873.SGD","LU2264538146.SGD","LU0048573561.USD","LU1035773651.USD","BK4125","LU2505996509.AUD","IE00BN29S564.USD","LU0069063385.USD","LU0130103400.USD","LU1988902786.USD","LU2065170008.USD","LU0348723411.USD","LU2065169927.USD","LU0128525929.USD","LU2272731865.HKD","SG9999000418.SGD","LU2746668461.USD","SG9999014898.SGD","LU2322448791.USD","LU2552382215.SGD","LU1935043023.USD","LU2108987350.USD","SG9999004303.SGD","IE00BDRTCR15.USD","BK4567","LU1674673428.USD","LU2023251221.USD","LU1201861165.SGD","LU0080751232.USD","IE00BKDWB100.SGD","NVDS","LU0265550359.USD","LU0203202063.USD","IE0004091025.USD","LU0130517989.USD","LU0417517546.SGD","LU2191332357.HKD","LU2417539215.USD","LU0274383776.USD","LU0072461881.USD","LU2506951792.HKD","IE0003U64NQ7.SGD","LU2125154778.USD","LU1868837300.USD","LU0820561818.USD","LU1951200564.SGD","LU0225283273.USD","LU1066053197.SGD","BK4141","BK4201","LU0466842654.USD","LU0557290698.USD","LU0957808578.USD","IE00B7SZLL34.SGD","BK4139","DHI","LU0130102774.USD","LU0314106906.USD","LU2487616109.SGD","LU2125909759.SGD","LU2290526834.HKD","LU1069347547.HKD","LU0965509010.AUD","IE00B7KXQ091.USD","IE00BZ199S13.USD","LU0070302665.USD","LU1267930227.SGD","LU1261432733.SGD","LU1244550221.USD","LU1035775433.USD","LU2249611893.SGD","NVII","LU2543165471.USD","NVIW.SI","IE0004445239.USD","LU0345770308.USD","LU1551013425.SGD","LU0354030438.USD","LU1823568750.SGD","LU0130518102.USD","NVDU","LU1992135399.USD","2NVD.UK","SG9999014542.SGD","LU0314104364.USD","LU1974910355.USD","LU1162221912.USD","IE0034235303.USD","BK4108","LU0109392836.USD","LU2168564222.USD","BK4504","LU0823414478.USD","IE00BHPRN162.USD","LU0957791311.USD","LU2286300806.USD","SG9999014906.USD","LU1037948897.HKD","LU1074936037.SGD","BK4534","LU1720051017.SGD","IE00BMPRXQ63.HKD","LU0444971666.USD","LU0320765646.SGD","SG9999014567.USD","LU0203201768.USD","LU0006306889.USD","IE00B775H168.HKD","LU0511384066.AUD","LU2089283258.USD","NVDQ","LU2430703095.HKD","LU0889565833.HKD","LU0094547139.USD","LU2602419157.SGD","SNVD.UK","LU2592432038.USD","LU2750360641.GBP","LU0683600562.USD","LU1923622614.USD","LU0266013472.USD","LU1791807156.HKD","LU0321505868.SGD","LU0528227936.USD","LU2213496289.HKD","LU2458330243.SGD","LU2458330169.SGD","LU2860962120.EUR","LU1064131342.USD","LU0320765059.SGD","LU2360106780.USD","LU1791710582.SGD","BK4529","LU0823414551.USD","NVDL","NVDG","LU0345770993.USD","LU0149725797.USD","LU0494093205.USD","LU2931357623.SGD","LU0215105999.USD","LU1914381329.SGD","LU2413666426.HKD","NVDX","LU0256863902.USD","LU0029864427.USD","LU0444973449.USD","LU2473716301.USD","LU0170899867.USD","LU1145028129.USD","LU0158827948.USD","LU0267386448.USD","BK4503","LU1852331112.SGD","LU2168564149.EUR","LU0098860793.USD","LU1232071149.USD","LU0345768153.USD","LU2087625088.SGD","LU0742534661.SGD","LU2272731600.USD","LU0052756011.USD","SG9999014914.USD","LU0096364046.USD","LU0077335932.USD","BK4614","BK4532","IE00B19Z3581.USD","LU2746668974.SGD","LU0053666078.USD","LU0476273544.USD","LU2129689431.USD","LU2491050071.SGD","LU0289960550.SGD","IE00B3SWFQ91.USD","LU0648000940.SGD","SG9999018857.SGD","LU1868836914.USD","SG9999015952.SGD","LU0082616367.USD","GB00BDT5M118.USD","LU1435385759.SGD","LU1267930730.SGD","LU0265550946.USD","NVD3.UK","IE00B5949003.HKD","LU0203347892.USD","LU1720051108.HKD","BK4587","LU2357125470.USD","LU2089284900.SGD","IE000KEQY171.SGD","LU0342679015.USD","LU0234570918.USD","LU0823434583.USD","SG9999014559.SGD","SG9999017495.SGD","LU0158827781.USD","LU0323591593.USD","LU2452424414.USD","LU1699723380.USD","LU2129689605.HKD","LU0321505439.SGD","LU0672654240.SGD","LU0820561909.HKD","LU2133065610.SGD","BK4566","IE0034235295.USD","IE00BQXX3C00.GBP","LU0943347566.SGD","LU0162691827.USD","BK4561","LU2237957811.SGD","LU1046421795.USD","LU0472753341.HKD","LU1861220033.SGD","LU0289961442.SGD","LU0689472784.USD","LU2083900584.USD","IE0034235188.USD","LU0979878070.USD","LU1429558221.USD","LU1894683264.USD","HK0000914660.USD","LU2125909593.SGD","LU0057025933.USD","LU0198837287.USD","LU2552382132.HKD","LU2750360997.AUD","LU1721428933.USD","LU0208291251.USD","LU1821325948.USD","LU2491050154.USD","NVDW","LU0689626769.HKD","BK4559","LU0211328371.USD","LU1803068979.SGD","SG9999014880.SGD","BK4527","HK0000914686.HKD","LU0971096721.USD","LU1066051498.USD","LU1934455277.USD","TGTX","LU2111349929.HKD","LU1116320901.HKD","LU1989772840.SGD","SG9999015986.USD","LU2242649171.HKD","IE00B4JS1V06.HKD","LU1935042215.USD","LU1633808545.USD","LU1861215975.USD","LU0061475181.USD","LU1923623000.USD","LU2168564065.EUR","LU2463028550.USD","LU2125909247.SGD","BK4501","C","IE00B19Z9505.USD","LU0048584097.USD","SG9999015358.SGD","LU0964807845.USD","LU2087621335.USD","LU0347712357.USD","LU2505996681.GBP","LEN","LU1791710400.SGD","SGXZ99366536.SGD","LU1934455194.USD","LU0477156797.USD","LU0823434740.USD"],"gpt_icon":1},{"id":"1178336933","title":"异动解读 | 初步销售额超预期及2026年营收指引乐观，TG Therapeutics夜盘大涨7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178336933","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178336933?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:40","pubTimestamp":1768380055,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.（TGTX）今日夜盘大涨7.61%，股价表现强劲。消息面上，公司公布的2025年初步净销售额为6.16亿美元，超出此前预期的6亿美元。同时，公司对2026年的营收指引为8.75亿至9亿美元，显示出对未来增长的乐观预期。公司首席执行官Michael Weiss表示，若多发性硬化症药物Briumvi获得批准，新的静脉输注计划有望短期内提升收入，进一步增强了市场信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"1150259462","title":"TG Therapeutics公布2025年第四季度及全年初步净产品收入、2026年营收指引与预期研发里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1150259462","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150259462?lang=zh_cn&edition=full","pubTime":"2026-01-14 05:26","pubTimestamp":1768339575,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.披露了2025年第四季度及全年的初步净产品收入数据，同时公布了2026年的营收预期指引以及公司计划达成的关键研发里程碑。这些信息反映了公司在商业化进程和研发管线推进方面的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","TGTX"],"gpt_icon":0},{"id":"1152917435","title":"TG Therapeutics完成Briumvi新简化给药方案的三期Enhance试验的入组工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1152917435","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152917435?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:31","pubTimestamp":1761651075,"startTime":"0","endTime":"0","summary":"TG Therapeutics完成了关于其新简化给药方案Briumvi的三期Enhance试验的入组工作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TGTX","BK4139","BK4588"],"gpt_icon":0},{"id":"1142145272","title":"TG Therapeutics宣布将在2025年欧洲多发性硬化症治疗和研究委员会年会上公布Briumvi®多发性硬化症数据展示安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1142145272","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142145272?lang=zh_cn&edition=full","pubTime":"2025-09-10 19:31","pubTimestamp":1757503884,"startTime":"0","endTime":"0","summary":"TG Therapeutics宣布将在2025年欧洲多发性硬化症治疗和研究委员会年会上公布Briumvi®多发性硬化症数据展示安排","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","TGTX"],"gpt_icon":0},{"id":"1153229280","title":"TG Therapeutics宣布完成现有股份回购计划并授权新的1亿美元回购方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1153229280","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153229280?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:30","pubTimestamp":1756899033,"startTime":"0","endTime":"0","summary":"TG Therapeutics宣布已完成现有股份回购计划的执行，同时获得董事会授权启动新的1亿美元股份回购方案。\n该公司表示，此次新的股份回购计划将为公司提供更多资本配置的灵活性，体现了管理层对公司长期发展前景的信心。新的1亿美元回购授权将使公司能够根据市场条件和业务需要，适时回购公司股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TGTX","BK4588","BK4139"],"gpt_icon":0},{"id":"1170779365","title":"异动解读 | TG Therapeutics股价盘中大跌13.45%，季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1170779365","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170779365?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:41","pubTimestamp":1754314908,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.周一盘中股价大跌13.45%，引发市场关注。这家生物制药公司今日公布的第二季度财报显示业绩未能达到分析师预期，导致投资者信心受挫。尽管本季度业绩不及预期，但分析师对TG Therapeutics的长期前景仍保持乐观态度。然而，投资者似乎更关注短期业绩，导致股价出现大幅下跌。值得注意的是，TG Therapeutics今年迄今为止的股价仍上涨了16.3%，显示出公司在生物制药领域的潜力。未来公司能否改善业绩表现，将继续受到市场密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"1145197562","title":"异动解读 | TG Therapeutics股价盘中暴跌13.45%，财报公布在即投资者忧虑加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1145197562","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145197562?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:40","pubTimestamp":1754314836,"startTime":"0","endTime":"0","summary":"周一盘中，生物制药公司TG Therapeutics Inc.股价大幅下挫，跌幅高达13.45%，引发市场广泛关注。这一显著跌幅出现在公司即将公布第二季度财报之际，反映出投资者对公司业绩的担忧情绪正在加剧。根据公司此前安排，TG Therapeutics将于周一早上7:00公布2025年第二季度财报。部分投资者可能选择在财报公布前提前卖出股票以规避潜在风险。投资者现在将密切关注TG Therapeutics的财报内容，以评估公司的实际经营状况和未来发展前景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"2518744086","title":"Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元，同比增加84.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518744086?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449668,"startTime":"0","endTime":"0","summary":"3月9日，Tg Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为23.38百万美元，同比增加84.53%；其中营业收入为3.29亿美元，同比增加40.60%，每股基本收益为0.16美元。机构评级：截至2025年3月9日，当前有6家机构对Tg Therapeutics, Inc.目标价做出预测，其中目标均价为42.83美元，其中最低目标价为10.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230a266b3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230a266b3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TGTX"],"gpt_icon":0},{"id":"2517162677","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162677?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277052,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分，Tg Therapeutics, Inc.股票出现波动，股价快速拉升5.04%。截至发稿，该股报36.88美元/股，成交量108.177万股，换手率0.69%，振幅6.61%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000412989ec607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000412989ec607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4139","BK4585","TGTX"],"gpt_icon":0},{"id":"2516711677","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516711677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516711677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:37","pubTimestamp":1741099069,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时37分，Tg Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1090.78%、1079.98%、427.26%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Pliant Therapeutics, Inc.，振幅分别为23.30%、22.25%、14.49%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223749abe7f1dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223749abe7f1dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","BK4139","BK4585","LENZ"],"gpt_icon":0},{"id":"1131727124","title":"TG Therapeutics 2024年第四季度GAAP每股收益$0.15，与预期一致，销售额$108.19M超$99.95M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1131727124","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131727124?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741004021,"startTime":"0","endTime":"0","summary":"TG Therapeutics公布季度每股收益为$0.15，符合分析师的一致预期。公司本季度销售额为$108.19百万，超过分析师预期的$99.95百万，超出8.24%。与去年同期的$43.97百万销售额相比，这是一个146.04%的增长。以上内容来自Benzinga Earnings专栏，原文如下：TG $Therapeutics$ reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. This is a 250 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $108.19 million which beat the analyst consensus estimate of $99.95 million by 8.24 percent. This is a 146.04","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX","TG"],"gpt_icon":0},{"id":"2516301606","title":"Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301606?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:50","pubTimestamp":1740775803,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时50分，Tg Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045003abe13d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045003abe13d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","TGTX","LENZ","BK4139","BK4588"],"gpt_icon":0},{"id":"2514703346","title":"Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703346?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:22","pubTimestamp":1740428567,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时22分，Tg Therapeutics, Inc.股票出现波动，股价大幅跳水5.12%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为327.09%、142.18%、41.18%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504224798913a0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504224798913a0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","TGTX","LENZ"],"gpt_icon":0},{"id":"2508997936","title":"Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508997936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508997936?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:54","pubTimestamp":1738356887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时54分，Tg Therapeutics, Inc.股票出现异动，股价快速跳水5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045447a2358435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045447a2358435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2506309359","title":"Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506309359?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991499,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分，Tg Therapeutics, Inc.股票出现波动，股价急速拉升5.05%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1801.77%、202.36%、197.33%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Dogwood Therapeutics, Inc.，振幅分别为85.35%、65.16%、61.84%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232459961241f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232459961241f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","TGTX","LENZ","BK4585"],"gpt_icon":0},{"id":"2506941228","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.03%报30.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506941228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506941228?lang=zh_cn&edition=full","pubTime":"2025-01-25 02:55","pubTimestamp":1737744942,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日02时55分，Tg Therapeutics, Inc.股票出现异动，股价快速上涨5.03%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Neuphoria Therapeutics Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4273.07%、2353.10%、1709.92%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As，振幅分别为261.67%、185.76%、137.09%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125025542a22e91e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125025542a22e91e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4588","BK4585","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tgtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.111},{"period":"3month","weight":-0.2049},{"period":"6month","weight":-0.2888},{"period":"1year","weight":0.0072},{"period":"ytd","weight":-0.0651}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司，专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外，TG还获得了美国食品药品监督管理局（FDA）的BRIUMVI（ublituximab-xiiy）批准，用于治疗成人复发性多发性硬化症（RMS）患者，包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.046178},{"month":2,"riseRate":0.666667,"avgChangeRate":0.075535},{"month":3,"riseRate":0.666667,"avgChangeRate":0.113076},{"month":4,"riseRate":0.416667,"avgChangeRate":0.02059},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003449},{"month":6,"riseRate":0.538462,"avgChangeRate":0.05525},{"month":7,"riseRate":0.384615,"avgChangeRate":-0.001846},{"month":8,"riseRate":0.538462,"avgChangeRate":-0.030643},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.032476},{"month":10,"riseRate":0.307692,"avgChangeRate":-0.061104},{"month":11,"riseRate":0.846154,"avgChangeRate":0.172847},{"month":12,"riseRate":0.461538,"avgChangeRate":0.09546}],"exchange":"NASDAQ","name":"TG Therapeutics Inc.","nameEN":"TG Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TG Therapeutics Inc.,TGTX,TG Therapeutics Inc.股票,TG Therapeutics Inc.股票老虎,TG Therapeutics Inc.股票老虎国际,TG Therapeutics Inc.行情,TG Therapeutics Inc.股票行情,TG Therapeutics Inc.股价,TG Therapeutics Inc.股市,TG Therapeutics Inc.股票价格,TG Therapeutics Inc.股票交易,TG Therapeutics Inc.股票购买,TG Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}